Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Arch Gerontol Geriatr ; 48(3): 406-10, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-18456352

RESUMEN

Although the role of inflammation has been studied in specific diseases or in community living elderly, data in hospitalized acute care elderly patients are scarce. The present study was designed to determine the predictive value of sociodemographic, clinical and biological factors for mortality in acute care geriatric wards. Retrospective study was conducted in two acute care wards in a university-based geriatric hospital with elderly patients (n=224) consecutively admitted to acute care wards with available medical files. Sociodemographic variables, primary medical diagnosis and number of associated conditions, dementia, depression, pressure sores, functional status (measure by the activities of daily living=ADL scale), weight, and plasma levels of albumin, transthyretin, C-reactive protein (CRP) and orosomucoid were recorded at admission. Patients who died in the acute care wards were compared to those who survived. The mean length of stay was 16+/-13 days; mortality was 12%. Univariate analysis revealed that disability, no anti-depressant drug, pressure ulcers, a higher number of associated conditions, living with another person, and biological markers of malnutrition (albumin <35g/l, transthyretin <200mg/l) and inflammation (CRP < or =30mg/l, orosomucoid > or =1.25g/l) were significantly associated with an increase in the risk of death. The logistic regression model retained CRP > or =30mg/l (odds ratio (OR)=3.72, 95% confidence interval (CI)=1.34-10.31; p=0.009) and disability for at least one ADL item (OR=2.16, 95% CI=1.55-2.99; p<0.001) as independent risk factors for death. We conclude that CRP and disability are strong independent risk factors for death in this population, and special attention should be paid to these patients in an integrated therapeutic approach to geriatric care.


Asunto(s)
Evaluación de la Discapacidad , Inflamación/mortalidad , Actividades Cotidianas , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Proteína C-Reactiva/metabolismo , Distribución de Chi-Cuadrado , Comorbilidad , Femenino , Humanos , Inflamación/sangre , Modelos Logísticos , Masculino , Orosomucoide/metabolismo , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Factores de Riesgo , Estadísticas no Paramétricas
2.
Fundam Clin Pharmacol ; 18(4): 437-47, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15312150

RESUMEN

Some combinations of antihypertensive agents were shown to reduce proteinuria in patients with renal failure. However, preventive effects of such combinations on renal structure and function are presently unknown when treatment is administered before the onset of renal abnormalities. We thus investigated the long-term effects of an angiotensin-converting enzyme (ACE) inhibitor (perindopril)/diuretic (indapamide) combination (per/ind) in the Zucker rat, a classical model of chronic renal failure associated with obesity, hyperlipidemia, and insulin resistance. Two-month-old lean and obese Zucker rats, presenting normal renal structure and function at this young age, received per/ind (0.76 + 0.24 mg/kg of body weight/day) or the vehicle of this combination by daily gavage. After 8.5 consecutive months of treatment, those 10.5-month-old rats were used for determination of renal structural and functional parameters which were examined using standard renal clearance experiments and kidney tissue analysis. Per/ind prevented focal and segmental glomerular hyalinosis and tubulo-interstitial damage in obese rats. Treatment was also associated with a significant reduction in several staining markers of glomerular and interstitial fibrosis. The hypertrophy of superficial glomeruli and the mesangial expansion of deep glomeruli observed in control rats were reduced in per/ind-treated obese rats. The severe proteinuria observed in 10.5-month-old control obese rats was prevented by per/ind, while glomerular filtration and renal hemodynamic parameters reached similar values to those obtained in lean animals. These results show that long-term treatment with this ACE inhibitor/diuretic combination protects renal structure and function in the obese Zucker rat, emphasizing the potential efficiency of such therapy in renal failure prevention.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Diuréticos/uso terapéutico , Indapamida/uso terapéutico , Perindopril/uso terapéutico , Proteinuria/prevención & control , Insuficiencia Renal/prevención & control , Inhibidores de la Enzima Convertidora de Angiotensina/administración & dosificación , Inhibidores de la Enzima Convertidora de Angiotensina/farmacocinética , Animales , Diuréticos/administración & dosificación , Diuréticos/farmacocinética , Combinación de Medicamentos , Fibrosis/prevención & control , Indapamida/administración & dosificación , Indapamida/farmacocinética , Pruebas de Función Renal , Masculino , Tasa de Depuración Metabólica , Obesidad/complicaciones , Perindopril/administración & dosificación , Perindopril/farmacocinética , Proteinuria/etiología , Ratas , Ratas Zucker , Insuficiencia Renal/etiología , Insuficiencia Renal/patología
3.
Am J Physiol Regul Integr Comp Physiol ; 286(4): R793-800, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-14670809

RESUMEN

Chronic renal failure often induces left ventricular hypertrophy. We assessed whether the heart is affected in the Zucker obese rat, a model of chronic renal failure associated with obesity, glucose intolerance, and insulin resistance without hypertension or hyperglycemia. After systemic blood pressure measurement, the heart, the aorta, and the kidneys were removed from anesthetized 9- and 13-mo-old Zucker obese and lean control male rats (n = 33, n = 24, n = 25, and n = 21, respectively). Determination of left ventricular geometry, quantification of myocardium collagen density, and measurement of heart antioxidant enzyme activity were made, as well as aorta and kidney parameters. Mean blood pressure remained at a normal range whatever the age and group considered. Whereas kidney structure and function were severely impaired, no sign of myocardial infarction or inflammatory process was noticed. A moderate left ventricular hypertrophy was observed in 13-mo-old obese rats. While heart malondialdehyde was stable with age and among groups, antioxidant enzyme activity was higher in obese rats. In conclusion, in the absence of hypertensive or hyperglycemic disorders, the heat seems to display a sufficient line of defense against oxidative stress during the development of cardiac hypertrophy.


Asunto(s)
Envejecimiento/metabolismo , Antioxidantes/metabolismo , Miocardio/metabolismo , Obesidad/metabolismo , Animales , Glucemia/metabolismo , Peso Corporal/fisiología , Colágeno/metabolismo , Vasos Coronarios/patología , Glutatión/metabolismo , Ventrículos Cardíacos/patología , Hemodinámica/fisiología , Inmunohistoquímica , Pruebas de Función Renal , Peroxidación de Lípido/fisiología , Masculino , Malondialdehído/metabolismo , Miocardio/patología , Obesidad/genética , Obesidad/patología , Tamaño de los Órganos/fisiología , Estrés Oxidativo/fisiología , Ratas , Ratas Zucker
4.
Obes Res ; 11(1): 112-20, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12529493

RESUMEN

OBJECTIVE: To correlate the susceptibility of low-(LDL) and very-low-density lipoprotein to oxidation in vitro and the concentrations of serum antibodies against malondialdehyde-modified LDL and plasma vitamin E with the anthropometric and laboratory characteristics of obesity. RESEARCH METHODS AND PROCEDURES: A total of 75 nondiabetic, normotensive obese patients were assigned to one of four groups according to their body mass index (BMI): moderately obese (30 50 kg/m(2), n = 15). RESULTS: The oxidation lag time for LDL from patients with a BMI >or=35 kg/m(2) was shorter than that for LDL from non-obese controls (n = 13), whereas very-low-density lipoprotein oxidation lag times were not significantly different. The serum antibodies against modified LDL were similar in all groups, whereas the plasma vitamin E concentrations of obese patients were decreased (p

Asunto(s)
Peroxidación de Lípido , Obesidad/sangre , Vitamina E/sangre , Adulto , Consumo de Bebidas Alcohólicas , Anticuerpos/sangre , Constitución Corporal , Índice de Masa Corporal , Colesterol/sangre , Cobre/química , Femenino , Humanos , Lipoproteínas LDL/sangre , Lipoproteínas LDL/inmunología , Lipoproteínas VLDL/sangre , Masculino , Malondialdehído/farmacología , Persona de Mediana Edad , Obesidad Mórbida/sangre , Fumar , Triglicéridos/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA